Invus Public Equities, L.P. 13D and 13G filings for IGM Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-08-02 6:41 pm Purchase | 2024-07-25 | 13G | IGM Biosciences, Inc. IGMS | Invus Public Equities, L.P. | 3,330,422 9.900% | 3,330,422![]() (New Position) | Filing |